首页 | 本学科首页   官方微博 | 高级检索  
   检索      

定量蛋白质组学研究揭示知母可缓解2型糖尿病模型大鼠肝脏代谢异常
引用本文:门丽影,张涛,武舒佳,马百平,董悦生,常蕾,张瑶,徐平.定量蛋白质组学研究揭示知母可缓解2型糖尿病模型大鼠肝脏代谢异常[J].生物工程学报,2022,38(10):3888-3900.
作者姓名:门丽影  张涛  武舒佳  马百平  董悦生  常蕾  张瑶  徐平
作者单位:安徽医科大学 基础医学院, 安徽 合肥 230032;军事科学院军事医学研究院 生命组学研究所 中国医学科学院蛋白质组学与药物研发新技术创新单元国家蛋白质科学中心 (北京) 北京蛋白质组研究中心蛋白质组学国家重点实验室, 北京 102206;军事科学院军事医学研究院 辐射医学研究所, 北京 100850;大连理工大学 生物工程学院, 辽宁 大连 116024
基金项目:国家重点研发计划(2017YFA0505700);国家自然科学基金(31870824,81773867)
摘    要:2型糖尿病(type 2 diabetes mellitus,T2DM)是一种在全球范围内广泛存在的代谢性疾病,不及时治疗可能会引发众多危及生命的并发症。肝脏代谢在糖尿病发生发展的过程中扮演着至关重要的角色。目前已有报道中药知母用于缓解胰岛素抵抗及糖尿病,但其能否缓解糖尿病中肝脏代谢的异常仍有待深入研究。因此,提取了高脂饮食和化学药物链脲佐菌素(streptozotocin,STZ)诱导的2型糖尿病大鼠模型、知母提取物处理的2型糖尿病大鼠模型、高脂饮食大鼠模型以及正常饮食大鼠对照组的肝脏蛋白,通过基于质谱的定量蛋白质组学串联质量标签(tandem mass tag,TMT)标记技术获得定量蛋白质组数据。利用生物信息学软件对各组数据进行层次聚类分析及主成分分析,并以P<0.05,差异倍数(fold change)>1.5作为阈值标准进行火山图分析,发现知母提取物治疗组相较未治疗组与正常对照组更接近,表明肝脏组织定量蛋白质组数据能够反映知母提取物对2型糖尿病大鼠模型的治疗效果。筛选获得了表达水平与知母提取物治疗密切相关的关键蛋白簇。利用在线网站分析蛋白簇的GO功能与KEGG通路,发现知母缓解2型糖尿病模型大鼠肝脏脂肪酸代谢异常可能与关键蛋白Ndufa6和Prkar2b的表达水平回调有关。

关 键 词:2型糖尿病  肝脏  知母  定量蛋白质组学  脂肪酸代谢
收稿时间:2021/12/8 0:00:00

Quantitative proteomics reveals the abnormal liver metabolism-relieving effect of Anemarrhenae rhizoma in type 2 diabetes mellitus rats
MEN Liying,ZHANG Tao,WU Shuji,MA Baiping,DONG Yuesheng,CHANG Lei,ZHANG Yao,XU Ping.Quantitative proteomics reveals the abnormal liver metabolism-relieving effect of Anemarrhenae rhizoma in type 2 diabetes mellitus rats[J].Chinese Journal of Biotechnology,2022,38(10):3888-3900.
Authors:MEN Liying  ZHANG Tao  WU Shuji  MA Baiping  DONG Yuesheng  CHANG Lei  ZHANG Yao  XU Ping
Institution:School of Basic Medicine, Anhui Medical University Hefei 230032, Anhui, China;State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug, Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Academy of Military Medical Sciences of Academy of Military Science, Beijing 102206, China;Institute of Radiation Medicine, Academy of Military Medical Sciences of Academy of Military Science, Beijing 100850, China;School of Bioengineering, Dalian University of Technology, Dalian 116024, Liaoning, China
Abstract:Type 2 diabetes mellitus (T2DM) is a global metabolic disease with potentially life- threatening complications. Liver metabolism plays a vital role in the occurrence and development of diabetes mellitus. It has been reported that the Chinese medicinal Anemarrhenae rhizoma (AR) can relieve insulin resistance and diabetes mellitus. However, the effect on abnormal liver metabolism in diabetes mellitus is still unclear. Therefore, we extracted liver proteins of T2DM rats induced by high-fat diet (HFD) and streptozotocin (STZ), T2DM rats treated with AR extract (ARE), obesity rats (fed with HFD), and normal control rats (fed with normal diet). Then, through tandem mass tag (TMT) labeling combined with mass spectrometry (MS), we obtained the quantitative proteomic data. Bioinformatics software was used for hierarchical cluster analysis and principal component analysis of the data in each group. The volcano map for differentially expressed proteins (P < 0.05, fold change > 1.5) was plotted. It was found that the treatment group was closer to the normal control group, indicating that the quantitative proteomic data of liver tissue can reflect the therapeutic effect of ARE on T2DM rats. Key protein clusters closely related to the treatment of ARE were screened out. The Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of the protein clusters were analyzed by David, and the result showed that AR''s alleviation of abnormal fatty acid metabolism in livers of T2DM rats may be related to the regulation of the expression of key proteins Ndufa6 and Prkar2b.
Keywords:type 2 diabetes mellitus  liver  Anemarrhenae rhizoma  quantitative proteomics  fatty acid metabolism
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号